Welcome to our dedicated page for Danaher Corporation SEC filings (Ticker: DHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Danaher Corporation filings document the regulatory record of a public life sciences and diagnostics company with common stock and multiple senior note series registered on the New York Stock Exchange. Its 8-K reports cover operating and financial results, material-event disclosures, capital-structure matters and material agreements, including revolving credit facilities and debt-related disclosures.
Danaher proxy materials describe shareholder voting matters, board governance, executive compensation and related annual-meeting subjects. Other filings address exchange registration changes for specific securities, ownership and governance matters, and the formal disclosure framework surrounding the company’s public securities and financing arrangements.
Danaher Corporation has created new long-term debt through a private placement of multiple Swiss franc–denominated senior notes issued by wholly owned subsidiary DH Masi Finance Inc. and guaranteed by Danaher. The company sold CHF 119,500,000 of 1.65% Series A Notes due June 3, 2031 and CHF 137,410,000 of 1.88% Series B Notes due June 3, 2033, alongside larger tranches maturing between 2036 and 2056 at fixed interest rates ranging from 2.10% to 2.51% per year. Interest is payable semi-annually on June 3 and December 3, starting December 3, 2026. Net proceeds are expected to be used for general corporate purposes, including working capital, acquisitions and share repurchases.
Danaher Corporation director Linda Filler reported new equity awards and updated holdings. She received 680 shares of common stock as a grant reported in Table I, and 1,699 director stock options with a conversion price of $161.9100 per share, expiring on May 15, 2036.
According to the footnote, these 680 units are restricted stock units payable solely in common stock. They vest on the earlier of the first anniversary of the grant date or immediately before the next annual shareholder meeting, with shares issued on the earlier of the director’s death or the first day of the seventh month after retirement from the Board.
After these awards, Filler directly holds 24,712.403 common shares and 1,699 options, and indirectly holds 21,590 common shares through a trust. The filing reflects equity awards rather than open-market buying or selling.
Danaher Corporation senior vice president Georgeann Couchara reported a small tax-related share disposition. On this Form 4, 281 shares of Danaher common stock were delivered at a price of $161.91 per share to satisfy tax obligations. After this non‑market tax-withholding transaction, she directly holds 8,291 common shares.
Danaher Corporation director Raymond C. Stevens reported equity awards rather than open-market trades. He received 680 restricted stock units that are payable solely in common stock, reported as common shares. These RSUs vest on the earlier of the first anniversary of the grant date or the next annual shareholder meeting.
Stevens was also granted director stock options on 1,699 underlying common shares at an exercise price of $161.91 per share, expiring on May 15, 2036. Following these awards, he directly holds 13,728.286 shares of common stock and 1,699 director stock options. The underlying RSU shares will not be issued until the earlier of his death or several months after retirement from the Board.
Danaher Corporation director Alan G. Spoon reported new equity awards and updated his holdings. He received a grant of 680 restricted stock units (RSUs) payable in common stock and a separate grant of director stock options covering 1,699 shares at an exercise price of $161.9100 per share.
The RSUs vest on the earlier of one year from the grant date or immediately before the next annual shareholder meeting, with actual shares issued only after the director’s death or several months after retirement from the Board. Following these awards, Spoon holds 124,773.689 common shares directly and 8,700 shares indirectly through an LLC.
Danaher Corporation director A. Shane Sanders reported equity awards received as compensation. On 2026-05-15, Sanders acquired 680 shares in the form of restricted stock units (RSUs) that are payable solely in common stock, bringing direct holdings to 5,914.088 shares.
On the same date, Sanders also received director stock options covering 1,699 shares of common stock at an exercise price of $161.9100 per share, expiring on 2036-05-15. The RSUs vest on the earlier of the first anniversary of the grant date or the next annual shareholder meeting, while the underlying shares are issued only after the director’s death or a set period following retirement from the Board.
Danaher Corporation director Teri List received new equity awards, increasing her ownership stake. She was granted 680 restricted stock units payable in common stock and a director stock option for 1,699 shares at an exercise price of $161.91 per share. Following these awards, she holds 21,470.399 common shares directly and 1,699 options. The RSUs vest on the earlier of one year from grant or the next annual shareholder meeting, while the underlying shares are issued only after the director’s death or several months after retirement from the Board.
Danaher Corporation director Elias A. Zerhouni reported new equity awards and updated holdings. He received 680 restricted stock units payable in common stock and 1,699 director stock options with a $161.91 exercise price, expiring on May 15, 2036.
After these awards, he holds 43,186.282 shares of common stock directly and 7,500 shares indirectly through an LLC. The RSUs vest on the earlier of the first anniversary of the grant date or the next annual shareholder meeting, and the underlying shares are issued upon death or several months after Board retirement.
Danaher Corporation director Feroz Dewan reported equity awards received as part of his board compensation. He acquired 680 shares of common stock at no cost, bringing his direct holdings to 4,685.606 shares.
He was also granted a director stock option for 1,699 shares of common stock at an exercise price of $161.91 per share, expiring in 2036. According to the award terms, these restricted stock units vest on the earlier of one year after the grant date or immediately before the next annual shareholder meeting, but the underlying shares are not issued until the earlier of the director’s death or a set period after retirement from the board.
Danaher Corporation director Charles W. Lamanna reported equity awards received as part of his board compensation. He acquired 680 shares of common stock as restricted stock units and a director stock option covering 1,699 shares at an exercise price of $161.91 per share, expiring on May 15, 2036. Following the grant, he directly holds 1,359 common shares and 1,699 options. The RSUs vest on the earlier of the first anniversary of the grant date or the next annual shareholder meeting, and the underlying shares are issued upon death or several months after board retirement.